GSK aims to cut factory waste by two-thirds

GlaxoSmithKline is set on cutting waste from its factories around the world by two-thirds, to 30 kg for each kilogram of API produced from an average of 100 kg in 2005. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.